Lipo-C
Lipotropic Injection | MIC + B Vitamins
On this page
What is Lipo-C?
Lipo-C is a compounded blend of methionine, inositol, and choline (MIC) plus B vitamins — nutrients with documented roles in liver function and methylation, not a peptide. Researchers study these lipotropic nutrients for effects on liver lipid handling and insulin sensitivity, though the published evidence for the combined injection itself, specifically for weight management, remains limited. It's sold here strictly as a research formulation for laboratory study, not for use in people or animals.
Key terms:
Lipo-C is a lipotropic compound blend.
Lipo-C is a lipotropic injection — lipotropic means it helps the body process fat. It contains Methionine, Inositol, Choline (MIC), and B vitamins that support fat metabolism and liver function. These nutrients act as methyl donors and lipotropic agents. They assist in the breakdown and transport of fats. The individual components have documented metabolic roles. Clinical evidence for the combined injection specifically for weight reduction remains limited.
Key research areas
- Lipotropic nutrients (methionine, inositol, choline) support liver function and fat metabolism
- B vitamins contribute to energy metabolism
- Bypasses digestive absorption for direct nutrient delivery
- Supports methylation and Phase II liver detoxification
- Inositol component has evidence for improving insulin sensitivity, particularly in PCOS populations
Researched dosing
This table reflects how a lipotropic blend like this is typically dosed in research and clinical-practice settings — reference information for study design, not personal dosing guidance.
| Phase | Dose | Frequency | Route |
|---|---|---|---|
| General wellness studies | 1 mL | 1x weekly | IM or SubQ |
| Body-weight studies | 1-2 mL | 1-2x weekly | IM (clinic) or SubQ (home) |
| Liver studies | 1 mL | 1x weekly | IM or SubQ |
| B12-deficiency studies | 1 mL | Weekly initially, then monthly | IM preferred for B12 |
Commonly cycled 12 weeks on, 0+ weeks off.
How it works
At the cell level, Lipo-C research looks at how its methyl-donor nutrients (methionine, choline) support liver detoxification pathways and how inositol and B12 contribute to cellular signaling and methylation — nutrient biology rather than a single peptide mechanism.
MIC components act as methyl donors supporting Phase II liver detoxification and lipid transport. Choline prevents hepatic fat accumulation, methionine provides sulfur for glutathione synthesis, and inositol aids cellular signaling. B12 supports methylation pathways. Note: Clinical evidence for weight reduction specifically from MIC injections is limited.
Research applications
This section lists the body systems the individual MIC nutrients have been studied for — mainly liver function and methylation support, with more limited and mixed evidence for metabolic and weight-management research specifically — not medical claims about people.
Metabolic Health
Choline is essential for preventing fatty liver - deficiency directly causes hepatic fat accumulation. Lipotropic nutrients support healthy liver lipid processing. Methionine and choline serve as methyl donors, supporting SAMe production and Phase II liver detoxification pathways. Inositol component has moderate evidence for improving insulin sensitivity, particularly in PCOS populations, with documented reductions in fasting insulin.
Fat Reduction
Supports fat breakdown and transport; clinical evidence for weight reduction specifically from MIC injections alone is limited and typically requires accompanying diet and exercise.
Energy Metabolism
B vitamins contribute to energy metabolism and may provide energy improvements, particularly in those with B12 deficiency.
Dosage reference
- Doses used in research
- 1–2 mL per dose
- Frequency in studies
- 1-2x per week
- Handling
- Reconstituted solution — research use only; not for administration
- Timeline reported in studies
- Energy effects (if deficient): days to weeks. Weight/body composition: requires diet and exercise, effects modest over 4-12 weeks if any.
- Storage
- Check specific product - some room temperature, others require refrigeration. Protect from light.
- Cycle length
- 4-12 weeks typical program length
- Break between cycles
- Breaks not typically required - can be used ongoing as nutritional support
Interactions
This list shows which other metabolic-research compounds are commonly studied or co-administered alongside lipotropic blends like Lipo-C, and flags combinations that call for monitoring.
Reconstitution & storage
Lipo-C is typically supplied pre-mixed and ready to use, so this section covers dosing volume and storage notes rather than a powder-to-liquid preparation process.
- Lipo-C comes pre-mixed and ready to use - no reconstitution needed
- Draw prescribed volume (typically 1-2 mL) from multi-dose vial
- Store the reconstituted solution refrigerated (2–8°C), labeled with the date and concentration, for laboratory research use only.
Lyophilized: Room temperature or refrigerated (check product label), use within Per manufacturer expiry
Reconstituted: 2-6°C, use within Per product label; protect from light
Quality indicators
These are the sourcing and labeling checks researchers use to confirm a Lipo-C formulation is accurately labeled — since no single standardized formula exists, verifying the exact ingredient list and concentrations matters more here than with a single-molecule peptide.
Licensed Compounding Pharmacy - Obtain from accredited compounding pharmacy (look for PCAB accreditation) with proper sterility and quality controls.
Clear Labeling - Product should clearly list all ingredients with concentrations, lot number, expiration date, and storage requirements.
Healthcare Provider Prescription - Requires prescription from licensed provider who can assess appropriateness and monitor response.
Formulation Variations - No standardized formula exists. 'Lipo-C' from different providers may contain different ingredients and concentrations.
Added Medications - Some formulations include additional medications (semaglutide, phentermine, etc.) with their own significant risks and contraindications.
Unregulated Sources - Avoid products from non-licensed sources. FDA does not regulate compounded injections - quality varies significantly.
What to expect
This timeline summarizes what the limited available literature and reported observations describe at each stage — research context for comparing formulations, not a personal-results promise.
Possible energy improvement if B12 deficient. Mild injection site reactions possible.
Gradual effects if any. Do not expect dramatic weight reduction from injections alone.
Body composition changes require accompanying diet and exercise program.
Modest supportive benefits for those following comprehensive weight management.
Safety notes
This section covers handling cautions and regulatory notes for Lipo-C — including that compounded nutrient injections aren't FDA-regulated for quality — research-use-only scope, not medical safety advice for people.
- Methionine may worsen existing liver disease - contraindicated in advanced hepatic conditions
- Requires prescription from licensed healthcare provider
- Use only from reputable compounding pharmacies with proper quality controls
- Choline excess (>3,500mg/day) may cause fishy body odor, sweating, GI upset
- FDA does not regulate these compounded injections for quality, purity, or dosage
- Clinical evidence for MIC injections specifically causing weight reduction is limited
Regulatory status
- Not approved by the FDA for any indication.
- Supplied and described for laboratory research use only — not for human or veterinary use.
Community data
Community Insights
Based on data the community reported. Not clinical proof.
References
Demonstrated that humans consuming diets low in choline develop fatty liver and hepatic damage, establishing choline's essential role in liver lipid metabolism.
Systematic review found inositol effective for insulin sensitivity in PCOS, with improvements in fasting insulin and metabolic markers, though guidelines note evidence remains 'limited and inconclusive.'
Meta-analysis of 37 randomized controlled trials showed L-carnitine supplementation resulted in modest but significant weight reduction (-1.21 kg) and fat mass reduction (-2.08 kg), primarily when combined with exercise.